DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Panhematin (Hemin) - Summary

 

-- advertisement --

PANHEMATIN SUMMARY

PANHEMATIN (hemin for injection) is an enzyme inhibitor derived from processed red blood cells. Hemin for injection was known previously as hematin. The term hematin has been used to describe the chemical reaction product of hemin and sodium carbonate solution. Hemin is an iron containing metalloporphyrin.

PANHEMATIN (hemin for injection) is indicated for the amelioration of recurrent attacks of acute intermittent porphyria temporally related to the menstrual cycle in susceptible women.

Manifestations such as pain, hypertension, tachycardia, abnormal mental status and mild to progressive neurologic signs may be controlled in selected patients with this disorder.

Similar findings have been reported in other patients with acute intermittent porphyria, porphyria variegata and hereditary coproporphyria. PANHEMATIN is not indicated in porphyria cutanea tarda.

PANHEMATIN NEWS HIGHLIGHTS

Published Studies Related to Panhematin (Hemin)

Hemin, a heme oxygenase-1 inducer, improves aortic endothelial dysfunction in insulin resistant rats. [2008.02.05]

Effect of hemin and carbon monoxide releasing molecule (CORM-3) on cGMP in rat penile tissue. [2008.02]

Protective effects of hemin pretreatment combined with ulinastatin on septic shock in rats. [2008.01.05]

Dry powder inhalation of hemin to induce heme oxygenase expression in the lung. [2007.11]

Heme oxygenase-1 induction by hemin protects liver cells from ischemia/reperfusion injury in cirrhotic rats. [2007.10.28]

more>>

Clinical Trials Related to Panhematin (Hemin)

Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS [Recruiting]

more>>

Page last updated: 2008-06-22

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008